[1] |
WANG Zifei, DING Yahui, LI Yan, LUAN Xin, TANG Min.
Application of 3D bioprinting in cancer research and tissue engineering
[J]. China Oncology, 2024, 34(9): 814-826.
|
[2] |
HUANG Haozhe, CHEN Hong, ZHENG Dezhong, CHEN Chao, WANG Ying, XU Lichao, WANG Yaohui, HE Xinhong, YANG Yuanyuan, LI Wentao.
A CT-based radiomics nomogram for predicting local tumor progression of colorectal cancer lung metastases treated with radiofrequency ablation
[J]. China Oncology, 2024, 34(9): 857-872.
|
[3] |
WU Wen, ZHANG Ruoxin, WENG Junyong, MA Yanlei, CAI Guoxiang, LI Xinxiang, YANG Yongzhi.
Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model
[J]. China Oncology, 2024, 34(9): 873-880.
|
[4] |
GE Zuyin, SONG Kun, LIN Yunxiao, ZHONG Yeling, HAO Jingduo.
The feasibility study of FCGBP and BIGH3 in circulating tumor cells as potential markers for colorectal cancer
[J]. China Oncology, 2024, 34(8): 745-752.
|
[5] |
WENG Junyong, YE Zilan, ZHANG Ruoxin, LIU Qi, LI Xinxiang.
Exploring the guiding role of the number of adverse pathological features in risk stratification for recurrence of stage Ⅰ-Ⅲ colorectal cancer: a retrospective cohort study of 9 875 cases
[J]. China Oncology, 2024, 34(6): 527-536.
|
[6] |
TANG Nan, HUANG Huixia, LIU Xiaojian.
Integrated single-cell sequencing and transcriptome sequencing to reveal a 9-gene prognostic signature of immune cells in colorectal cancer
[J]. China Oncology, 2024, 34(6): 548-560.
|
[7] |
CHEN Hong, CAO Zhiyun.
Recent progress in the construction and application of patient-derived pancreatic cancer organoid models
[J]. China Oncology, 2024, 34(6): 590-597.
|
[8] |
ZHANG Ruoxin, YE Zilan, WENG Junyong, LI Xinxiang.
Correlation study between advanced age and inferior prognosis in stage Ⅱ colorectal cancer patients
[J]. China Oncology, 2024, 34(5): 485-492.
|
[9] |
LU Yue, LU Renquan, ZHANG Jie, ZHENG Hui.
Application value of combined coagulation function indicators in monitoring hypercoagulable state of patients with colorectal cancer after chemotherapy
[J]. China Oncology, 2024, 34(3): 278-285.
|
[10] |
China Anti-Cancer Association Tumor Biomarker Professional Committee, Shanghai Anti-Cancer Association Tumor Biomarker Professional Committee.
Expert consensus on population-based BRCA germline mutation screening in China (2024 edition)
[J]. China Oncology, 2024, 34(2): 220-238.
|
[11] |
JIANG Yuanyuan, WEI Wenfei, WU Jingya, LI Huawen.
Application of organoids in drug screening of gynecological malignant tumors
[J]. China Oncology, 2024, 34(11): 1053-1060.
|
[12] |
LI Jun, LU Tingwei, FANG Xuqian.
Impact of MSI-H/dMMR on clinicopathological characteristics and prognosis of patients with BRAF V600E-mutated resectable colorectal cancer
[J]. China Oncology, 2024, 34(11): 1061-1066.
|
[13] |
WU Zhibai, XU Guiqin, ZHANG Li, YANG Zhaojuan, LIU Yun, JIAO Kun, CHEN Zehong, XU Chen, ZUO You, ZHENG Ningqian, YE Zhiqian, LIU Yongzhong.
Mechanism study of KCMF1 promoting proliferation and NF-κB signaling transduction in colorectal cancer cells
[J]. China Oncology, 2024, 34(11): 987-997.
|
[14] |
ZHANG Shaohua, LI Zhening, WANG Wei, WEI Yifan, HONG Yonggang, HAO Liqiang.
Research progress in the related treatment of KRAS mutant colorectal cancer
[J]. China Oncology, 2024, 34(10): 979-986.
|
[15] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|